Transchem

{
  "main_header": {
    "sid": 538955,
    "name": "Transchem",
    "stock_name": "Transchem",
    "full_name": "Transchem Ltd",
    "name_url": "stocks-analysis/transchem",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "163.95",
    "chg": 7.8,
    "chgp": "5.0%",
    "dir": 1,
    "prev_price": "156.15",
    "mcapval": "191.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 500422,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE019B01010",
    "curr_date": "Apr 15",
    "curr_time": "",
    "bse_nse_vol": "1.93 k",
    "exc_status": "Active",
    "traded_date": "Apr 15, 2026",
    "traded_date_str": "2026 04 15",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/transchem-538955-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Transchem Ltd Upgraded from Strong Sell to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/transchem-ltd-upgraded-from-strong-sell-to-sell-amid-mixed-financial-and-technical-signals-3944026",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/TranschemLtd_mojoScore_3944026.png",
        "date": "2026-04-13 08:02:57",
        "description": "Transchem Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 10 April 2026. This change is primarily driven by a marked improvement in technical indicators, even as the company continues to grapple with weak financial fundamentals and valuation concerns. The stock’s recent price surge and technical momentum have prompted a reassessment, though caution remains warranted given ongoing operational losses and negative returns on capital."
      },
      {
        "title": "Transchem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/transchem-ltd-is-rated-strong-sell-3934107",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/TranschemLtd_mojoScore_3934107.png",
        "date": "2026-04-06 10:10:39",
        "description": "Transchem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 02 March 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 06 April 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "Transchem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/transchem-ltd-is-rated-strong-sell-3917776",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/TranschemLtd_mojoScore_3917776.png",
        "date": "2026-03-26 10:10:36",
        "description": "Transchem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 2 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 March 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Transchem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/transchem-ltd-is-rated-strong-sell-3892043",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/TranschemLtd_mojoScore_3892043.png",
        "date": "2026-03-15 10:10:32",
        "description": "Transchem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 2 March 2026, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed below represent the stock's current position as of 15 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Transchem Ltd Downgraded to Strong Sell Amid Weak Financials and Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/transchem-ltd-downgraded-to-strong-sell-amid-weak-financials-and-mixed-technical-signals-3865851",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/TranschemLtd_mojoScore_3865851.png",
        "date": "2026-03-03 08:07:39",
        "description": "Transchem Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 2 March 2026, reflecting a complex interplay of deteriorating financial fundamentals, cautious valuation metrics, and mixed technical signals. Despite impressive long-term returns, recent quarterly losses and weakening operational metrics have raised concerns among analysts, prompting a reassessment of the stock’s outlook."
      },
      {
        "title": "Transchem Ltd Upgraded from Strong Sell to Sell Amid Mixed Technical and Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/transchem-ltd-upgraded-from-strong-sell-to-sell-amid-mixed-technical-and-financial-signals-3852138",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TranschemLtd_mojoScore_3852138.png",
        "date": "2026-02-24 08:04:10",
        "description": "Transchem Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by improved technical indicators despite ongoing financial challenges. The pharmaceutical and biotechnology company’s recent performance reveals a complex picture where technical momentum contrasts with deteriorating fundamentals, prompting a nuanced reassessment of its investment appeal."
      },
      {
        "title": "Transchem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/transchem-ltd-is-rated-strong-sell-3848082",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TranschemLtd_mojoScore_3848082.png",
        "date": "2026-02-20 10:10:49",
        "description": "Transchem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 10 February 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 20 February 2026, providing investors with the most up-to-date insight into the stock’s fundamentals and market performance."
      },
      {
        "title": "Transchem Ltd Investment Rating Upgraded to Sell on Technical Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/transchem-ltd-investment-rating-upgraded-to-sell-on-technical-improvements-3827980",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TranschemLtd_mojoScore_3827980.png",
        "date": "2026-02-09 08:03:07",
        "description": "Transchem Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 6 February 2026. This change reflects a nuanced shift in the company’s technical outlook despite ongoing financial challenges, with the MarketsMOJO Mojo Score adjusting to 31.0. Investors are advised to consider the detailed analysis across quality, valuation, financial trends, and technical indicators before making decisions."
      },
      {
        "title": "Are Transchem Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-transchem-ltd-latest-results-good-or-bad-3826811",
        "imagepath": "",
        "date": "2026-02-07 19:17:55",
        "description": "Transchem Ltd's latest financial results for Q2 FY26 reveal significant operational challenges, primarily characterized by a complete absence of net sales, which remained at ₹0.00 crore for two consecutive quarters. This stark situation contrasts sharply with the previous year, where minimal trading activity was recorded. The company reported a net profit of ₹0.68 crore, reflecting a decline of 31.31% quarter-on-quarter, driven largely by its reliance on other income, which accounted for ₹1.68 crore in the latest quarter. This other income represents a substantial 239.36% of profit before tax, underscoring the company's dependence on non-operating sources for its financial performance.\n\nThe operational metrics indicate that Transchem has not generated any meaningful sales since Q1 FY26, and its core business continues to incur losses, with an operating profit before depreciation, interest, and tax (excludin..."
      }
    ],
    "total": 174,
    "sid": "538955",
    "stock_news_url": "https://www.marketsmojo.com/news/transchem-538955"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Apr-2026",
      "details": "Please refer the attached intimation.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "24-Mar-2026",
      "details": "Please refer the attached intimation.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "09-Feb-2026",
      "details": "Please refer the attached intimation.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Transchem Ltd Upgraded from Strong Sell to Sell Amid Mixed Financial and Technical Signals

2026-04-13 08:02:57

Transchem Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 10 April 2026. This change is primarily driven by a marked improvement in technical indicators, even as the company continues to grapple with weak financial fundamentals and valuation concerns. The stock’s recent price surge and technical momentum have prompted a reassessment, though caution remains warranted given ongoing operational losses and negative returns on capital.

Read full news article

Transchem Ltd is Rated Strong Sell

2026-04-06 10:10:39

Transchem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 02 March 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 06 April 2026, providing investors with the latest perspective on the company’s position.

Read full news article

Transchem Ltd is Rated Strong Sell

2026-03-26 10:10:36

Transchem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 2 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 March 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Transchem Ltd is Rated Strong Sell

2026-03-15 10:10:32

Transchem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 2 March 2026, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed below represent the stock's current position as of 15 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Transchem Ltd Downgraded to Strong Sell Amid Weak Financials and Mixed Technical Signals

2026-03-03 08:07:39

Transchem Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 2 March 2026, reflecting a complex interplay of deteriorating financial fundamentals, cautious valuation metrics, and mixed technical signals. Despite impressive long-term returns, recent quarterly losses and weakening operational metrics have raised concerns among analysts, prompting a reassessment of the stock’s outlook.

Read full news article

Transchem Ltd Upgraded from Strong Sell to Sell Amid Mixed Technical and Financial Signals

2026-02-24 08:04:10

Transchem Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by improved technical indicators despite ongoing financial challenges. The pharmaceutical and biotechnology company’s recent performance reveals a complex picture where technical momentum contrasts with deteriorating fundamentals, prompting a nuanced reassessment of its investment appeal.

Read full news article

Transchem Ltd is Rated Strong Sell

2026-02-20 10:10:49

Transchem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 10 February 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 20 February 2026, providing investors with the most up-to-date insight into the stock’s fundamentals and market performance.

Read full news article

Transchem Ltd Investment Rating Upgraded to Sell on Technical Improvements

2026-02-09 08:03:07

Transchem Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 6 February 2026. This change reflects a nuanced shift in the company’s technical outlook despite ongoing financial challenges, with the MarketsMOJO Mojo Score adjusting to 31.0. Investors are advised to consider the detailed analysis across quality, valuation, financial trends, and technical indicators before making decisions.

Read full news article

Are Transchem Ltd latest results good or bad?

2026-02-07 19:17:55

Transchem Ltd's latest financial results for Q2 FY26 reveal significant operational challenges, primarily characterized by a complete absence of net sales, which remained at ₹0.00 crore for two consecutive quarters. This stark situation contrasts sharply with the previous year, where minimal trading activity was recorded. The company reported a net profit of ₹0.68 crore, reflecting a decline of 31.31% quarter-on-quarter, driven largely by its reliance on other income, which accounted for ₹1.68 crore in the latest quarter. This other income represents a substantial 239.36% of profit before tax, underscoring the company's dependence on non-operating sources for its financial performance. The operational metrics indicate that Transchem has not generated any meaningful sales since Q1 FY26, and its core business continues to incur losses, with an operating profit before depreciation, interest, and tax (excludin...

Read full news article

View All News